Table 3 Model performance in training and validation sets.

From: Relative expression orderings based prediction of treatment response to Anti-PD-1 immunotherapy in advanced melanoma

Datasets

ACC%

SEN%

SPE%

PPV%

NPV%

GSE91061_pre

100% (95% CI: 0.89-1)

100% (95% CI: 0.69-1)

100% (95% CI: 0.85-1)

100% (95% CI: 0.70-1)

100% (95% CI: 0.82-1)

GSE91061_on

89.47% (95% CI: 0.75–0.97)

84.61% (95% CI: 0.55–0.98)

92.00% (95% CI: 0.74–0.99)

84.61% (95% CI: 0.54–0.97)

92.00% (95% CI: 0.73–0.99)

GSE115821_pre

100% (95% CI: 0.63-1)

–

100% (95% CI: 0.63-1)

–

100% (95% CI: 0.60-1)

GSE115821_on

100% (95% CI: 0.82-1)

–

100% (95% CI: 0.82-1)

–

100% (95% CI: 0.78-1)